White P, Bradley C, Ferriter M, Hatzipetrou L
Queensland Centre for Schizophrenia Research, Wolston Park Hospital, Wolston Park Road, Wacol, Queensland, Australia, 4076.
Cochrane Database Syst Rev. 2000(2):CD000251. doi: 10.1002/14651858.CD000251.
The reviewers recognise that it may be thought that convicted sex offenders and those with disorders of sexual preference are quite different groups. In combining them within this review we have taken the view that legal process alone should not define the population. Illegal behaviours in one jurisdiction may not be considered so in others. Studies of those who are convicted of sexual offending describe reconviction rates for sexual offences of up to 40-60%. It would seem important to know if there are interventions that might reduce this high rate of re-offending. This review examines antilibidinal management of those who have been convicted of sexual offences or who have disorders of sexual preference.
To determine the effectiveness of a range of management techniques to assist people who have disorders of sexual preference and those who have been convicted of sexual offences.
Biological Abstracts, the Cochrane Schizophrenia Group Register of Trials, The Cochrane Library, EMBASE, MEDLINE, and PsychLIT were searched. Further references were sought from published trials and their authors. Relevant pharmaceutical manufacturers were contacted.
All relevant randomised controlled trials.
Reviewers evaluated data independently and analysed on an intention-to-treat basis. Data were extracted for short and medium term outcomes.
A single trial (McConaghy 1988) found the effect of antilibidinal medication (medroxyprogesterone acetate) plus imaginal desensitisation was no better than imaginal desensitisation for problematic/anomalous sexual behaviour and desire. A relapse prevention programme was trialed by Marques (Marques 1994) and participants were followed up for an average of 3 years. What data there are suggest that although there is no discernable effect on the outcome of sex offending (OR 0.76 CI 0. 26-2.28) those treated with response prevention do have less non-sexual violent offences (OR 0.3, CI 0.1-0.89, NNT 10 CI 5-85). In addition those committing both sexual and violent offences also declined in the response prevention group (OR 0.14 CI 0.02-0.98, NNT 20 CI 10-437). A large pragmatic trial investigated the value of group therapy for sex offenders (Romero 1983). This study finds no effect on recidivism at ten years.
REVIEWER'S CONCLUSIONS: It is disappointing to find that this area lacks a strong evidence base, particularly in light of the controversial nature of the treatment and the high levels of interest in the area. The relapse prevention programme did seem to have some effect on violent reoffending but large, well-conducted randomised trials of long duration are essential if the effectiveness or otherwise of these treatments are to be established.
评审人员认识到,可能有人认为已定罪的性犯罪者和有性偏好障碍的人是截然不同的群体。在本次综述中将他们合并考虑时,我们认为仅法律程序不应界定这一人群。在一个司法管辖区内的非法行为在其他司法管辖区可能不被视为非法。对那些被判性犯罪的人的研究表明,性犯罪的再定罪率高达40%-60%。了解是否存在可能降低这种高再犯率的干预措施似乎很重要。本综述考察了对已被判性犯罪或有性偏好障碍者的抗性欲管理。
确定一系列管理技术对有性偏好障碍者和已被判性犯罪者的有效性。
检索了《生物学文摘》、Cochrane精神分裂症研究组试验注册库、Cochrane图书馆、EMBASE、MEDLINE和PsychLIT。从已发表的试验及其作者处寻求更多参考文献。联系了相关制药厂商。
所有相关的随机对照试验。
评审人员独立评估数据,并按意向性分析原则进行分析。提取短期和中期结果的数据。
一项单一试验(McConaghy,1988年)发现,抗性欲药物(醋酸甲羟孕酮)加想象脱敏疗法对问题性/异常性行为和欲望的效果并不优于想象脱敏疗法。Marques进行了一项复发预防计划试验(Marques,1994年),对参与者平均随访了3年。现有数据表明,虽然对性犯罪结果没有明显影响(比值比0.76,可信区间0.26-2.28),但接受反应预防治疗的人非性暴力犯罪较少(比值比0.3,可信区间0.1-0.89,需治疗人数10,可信区间5-85)。此外,在反应预防组中,同时犯有性犯罪和暴力犯罪的人数也有所下降(比值比0.14,可信区间0.02-0.98,需治疗人数20,可信区间10-437)。一项大型实用试验研究了团体治疗对性犯罪者的价值(Romero,1983年)。该研究发现对十年后的累犯率没有影响。
令人失望的是,该领域缺乏有力的证据基础,特别是考虑到治疗的争议性以及该领域的高度关注度。复发预防计划似乎对暴力再犯有一定影响,但要确定这些治疗方法是否有效,必须进行大规模、实施良好的长期随机试验。